Numinus Wellness Inc.
NUMIF
$0.035
$0.007225.90%
| 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.36% | 37.65% | 93.58% | 227.14% | 584.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.36% | 37.65% | 93.58% | 227.14% | 584.61% |
| Cost of Revenue | 19.89% | 65.86% | 52.74% | 120.38% | 286.77% |
| Gross Profit | -12.60% | 47.18% | 38.65% | 224.75% | 970.49% |
| SG&A Expenses | -34.32% | -16.80% | -35.56% | -20.75% | 11.49% |
| Depreciation & Amortization | -32.25% | -10.39% | -19.18% | 15.70% | 145.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.53% | -6.75% | 7.42% | 31.07% | 79.54% |
| Operating Income | 38.92% | 30.15% | 24.79% | 13.45% | -20.04% |
| Income Before Tax | 51.51% | 47.68% | 56.76% | 52.14% | -30.39% |
| Income Tax Expenses | -84.62% | -10.23% | -10.23% | -10.23% | -- |
| Earnings from Continuing Operations | 51.60% | 47.73% | 56.81% | 52.19% | -30.30% |
| Earnings from Discontinued Operations | -68.41% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.44% | 42.36% | 40.72% | 35.92% | -56.03% |
| EBIT | 38.92% | 30.15% | 24.79% | 13.45% | -20.04% |
| EBITDA | 36.16% | 29.35% | 26.67% | 17.90% | -15.03% |
| EPS Basic | 53.43% | 47.30% | 47.72% | 45.17% | -39.89% |
| Normalized Basic EPS | 40.77% | 29.23% | 48.24% | 44.43% | 22.20% |
| EPS Diluted | 53.43% | 47.30% | 47.72% | 45.17% | -39.89% |
| Normalized Diluted EPS | 40.77% | 29.23% | 48.24% | 44.43% | 22.20% |
| Average Basic Shares Outstanding | 11.00% | 5.25% | 15.38% | 22.75% | 19.95% |
| Average Diluted Shares Outstanding | 11.00% | 5.25% | 15.38% | 22.75% | 19.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
